FINWIRES · TerminalLIVE
FINWIRES

Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116

By

Merck & Co. (MRK) has an average rating of overweight and mean price target of $145.24, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles

Research

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

Moderna (MRNA) has an average rating of hold and mean price target of $56.58, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $156.15, Change: $+93.19, Percent Change: +148.01%

$MRNA
Research

Morgan Stanley Upgrades Suncor Energy to Overweight From Equal Weight

Suncor Energy (SU) has an average rating of overweight and mean price target of CA$102, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $68.95, Change: $+1.27, Percent Change: +1.87%

$SU
Research

Morgan Stanley Downgrades Diamondback Energy to Equal Weight From Overweight

Diamondback Energy (FANG) has an average rating of buy and mean price target of $233, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $213.28, Change: $+3.26, Percent Change: +1.55%

$FANG